- Home
- FDP vs PVLA Comparison
FDP vs PVLA Comparison
Compare FDP & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FDP | PVLA |
|---|---|---|
| Founded | 1886 | 2015 |
| Country | Cayman Islands | United States |
| Employees | N/A | 14 |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.6B |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | FDP | PVLA |
|---|---|---|
| Price | $41.01 | $129.95 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 15 |
| Target Price | N/A | ★ $171.87 |
| AVG Volume (30 Days) | ★ 251.2K | 228.3K |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | ★ 2.88% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.88 | N/A |
| Revenue | ★ $4,322,300,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.14 | $102,383.52 |
| P/E Ratio | $22.13 | ★ N/A |
| Revenue Growth | ★ 0.98 | N/A |
| 52 Week Low | $31.70 | $20.20 |
| 52 Week High | $43.58 | $151.18 |
Technical Indicators
Market Signals| Indicator | FDP | PVLA |
|---|---|---|
| Relative Strength Index (RSI) | 46.42 | 58.51 |
| Support Level | $39.86 | $108.99 |
| Resistance Level | $43.30 | $133.06 |
| Average True Range (ATR) | 1.16 | 9.01 |
| MACD | -0.04 | 0.64 |
| Stochastic Oscillator | 40.65 | 83.37 |
Price Performance
Historical ComparisonAbout FDP Fresh Del Monte Produce Inc.
Fresh Del Monte Produce Inc is an integrated producer, marketer & distributor of fresh-cut fruit & vegetables. It operates in three segments, Fresh and value-added products segment, which includes pineapples, fresh-cut fruit, fresh-cut vegetables, melons, vegetables, non-tropical fruit, other fruit and vegetables, avocados, and prepared foods, Banana segment & Other products and services segment, including the third-party freight & logistic services business & the Jordanian poultry and meats business. The majority is from the Fresh and value-added products segment. Geographically, it operates in North America, Europe, Asia, the Middle East, and Other, out of which the highest is from North America.
About PVLA Palvella Therapeutics Inc.
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.